Abstract The World Health Organization Classification of Lymphoid Neoplasms identifies
Burkitt lymphoma/leukemia as a highly aggressive mature B-cell neoplasm consisting of …

PURPOSE: Primary mediastinal B-cell lymphoma (PMBL) is recognized as a separate
disease entity in the REAL classification. There is uncertainty about the relevance and …

Background The efficacy of autologous stem-cell transplantation during the first remission in
patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate …

BACKGROUND Adult Burkitt‐type lymphoma (BL) and acute lymphoblastic leukemia (B‐
ALL) are rare entities composing 1% to 5% of non‐Hodgkin lymphomas NHL) or ALL …

BACKGROUND AND OBJECTIVES: This multinational retrospective study compares the
outcomes of patients with primary mediastinal large B-cell lymphoma (PMLBCL) with …

Purpose This phase II trial evaluated the safety and efficacy of combining yttrium-90 (90Y)
ibritumomab tiuxetan with high-dose carmustine, cytarabine, etoposide, and melphalan …

Autologous stem cell transplantation (ASCT) has been successfully used in HIV-related
lymphoma (HIV-Ly) patients on highly active antiretroviral therapy. We report the first …

Background High‐dose chemotherapy with autologous stem cell support (HDT) has been
proven effective in relapsed aggressive non‐Hodgkin lymphoma (NHL). However …

Purpose Peripheral-blood autologous stem-cell transplantation (ASCT) in patients with HIV-
related lymphoma (HIV-Ly) has been reported as a safe and useful procedure. Herein we …

Background Third-generation regimens (MACOP-B [methotrexate/leucovorin
(LV)/doxorubicin/cyclophosphamide/vincristine/prednisone/bleomycin] or VACOP-B …